0.3390SEK-0.88%Mkt Cap: 140.27M SEKP/E: —Last update: 2026-05-13
iZafe Group AB (publ), a medical technology company, engages in the research, development, and marketing of digital medical solutions and services for safer drug management at home. The company provides Dosell, an automa…
Industry Peers
Medical Instruments & Suppliesloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
P/B5.75
P/S19.78
EV/EBITDA-7.75
EV/Revenue18.80
EPS (TTM)-0.06
EPS (Forward)—
Cash Flow & Leverage
FCF Yield0.53%
FCF Margin10.43%
Operating CF-14.56M SEK
CapEx (TTM)—
Net Debt/EBITDA0.40
Net Debt-6.93M SEK
Technical
SMA 500.3901 (-13.1%)
SMA 2000.4722 (-28.2%)
Beta-0.06
S&P 52W Chg24.23%
Avg Vol (30d)788.70K
Avg Vol (10d)747.95K
Technical Indicators
RSI (14)32.5
MACD-0.0154
MACD Signal-0.0118
MACD Hist.-0.0036
BB Upper0.4178 SEK
BB Middle0.3754 SEK
BB Lower0.3329 SEK
BB Width22.59%
ATR (14)0.0300 SEK
Vol Ratio (20d)0.18x
52W Range
0.230019% of range0.8000
52W High0.8000 SEK
52W Low0.2300 SEK
Profitability
Gross Margin40.13%
EBITDA Margin-242.55%
Profit Margin-278.35%
Oper. Margin-242.79%
ROE-142.71%
ROA-46.80%
Revenue Growth83.50%
Earnings Growth—
Balance Sheet
Debt/Equity0.01
Current Ratio0.99
Quick Ratio0.81
Book Value/Sh0.0600 SEK
Cash/Share0.0180 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split11:10
Split DateDec 7, 2011
Ownership
Shares Out.405.99M
Float397.62M
Insiders0.00%
Institutions1.42%
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Company
Market Cap140.27M SEK
Enterprise Value133.35M SEK
Revenue (TTM)7.09M SEK
Gross Profit2.40M SEK
Net Income (TTM)-16.68M SEK
Revenue/Share0.0200 SEK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees11
Last Price0.3390 SEK
CountrySE
SectorHealthcare
IndustryMedical Instruments & Supplies
ISIN—